Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
64.3M
-
Number of holders
-
177
-
Total 13F shares, excl. options
-
62.9M
-
Shares change
-
+9.25M
-
Total reported value, excl. options
-
$2.66B
-
Value change
-
+$390M
-
Put/Call ratio
-
1.67
-
Number of buys
-
118
-
Number of sells
-
-60
-
Price
-
$42.29
Significant Holders of Vera Therapeutics, Inc. - COMMON STOCK (VERA) as of Q4 2024
207 filings reported holding VERA - Vera Therapeutics, Inc. - COMMON STOCK as of Q4 2024.
Vera Therapeutics, Inc. - COMMON STOCK (VERA) has 177 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 62.9M shares
of 64.3M outstanding shares and own 97.8% of the company stock.
Largest 10 shareholders include Avoro Capital Advisors LLC (5.61M shares), PRICE T ROWE ASSOCIATES INC /MD/ (4.38M shares), BlackRock, Inc. (3.94M shares), FMR LLC (3.05M shares), VANGUARD GROUP INC (2.95M shares), Sofinnova Investments, Inc. (2.79M shares), STATE STREET CORP (2.03M shares), COMMODORE CAPITAL LP (1.96M shares), Holocene Advisors, LP (1.88M shares), and SAMLYN CAPITAL, LLC (1.66M shares).
This table shows the top 177 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.